Visualization of viral candidate cDNAs in infectious brain fractions from Creutzfeldt-Jakob disease by representational difference analysis

Journal of NeuroVirology

Volumn 2, Issue 4, 1996, Pages 240-248

  Dron, Michel ^a   Manuelidis, Laura ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bovine spongiform encephalopathy; RNA; Scrapie; Slow virus

Indexed keywords

COMPLEMENTARY DNA; NUCLEIC ACID; RNA; VIRUS DNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DNA HYBRIDIZATION; DNA SEQUENCE; DNA SYNTHESIS; GENE AMPLIFICATION; GENE SEQUENCE; HAMSTER; HUMAN; HUMAN TISSUE; MOLECULAR CLONING; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; VIRUS GENOME; VIRUS TITRATION;

BOVINAE; CRICETINAE; DNA VIRUSES;

EID: 0029844811     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289609146887     Document Type: Article

References (35)

1. Aiken JM, Williamson JL, Borchardt M, Marsh RF (1990). Presence of mitochondrial D-loop DNA in scrapie-infected brain preparations enriched for prion protein. J Virol 64: 3265-3268.
2. Akowitz A, Manuelidis L (1989). A novel cDNA/PCR strategy for efficient cloning of small amounts of undefined RNA. Gene 81: 295-306.
3. Akowitz A, Sklaviadis T, Manuelidis EE, Manuelidis L (1990). Nuclease resistant polyadenylated RNAs of significant size are detected by PCR in highly purified Creutzfeldt-Jakob disease preparations. Microb Pathogenesis 9: 33-45.
4. Akowitz A, Sklaviadis T, Manuelidis L (1994). Endogenous viral complexes with long RNA cosediment with the agent of Creutzfeldt-Jakob Disease. Nucleic Acids Res 22: 1101-1107.
5. Baldwin MA, Cohen FE, Prusiner SB (1995). Prion protein isoforms, a convergence of biological and structural investigations. J Biol Chem 270: 19197-19200.
6. Bessen RA, Kocisko DA, Raymond GJ, Nandan S, Lansbury PT, Caughey B (1995). Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 375: 698-700.
7. Bradley R (1996). Third International symposium on transmissible subacute spongiform encephalopathies: prion diseases. Paris, March 18-20, Abs #8.
8. Bruce ME, Dickinson AG (1987). Biological evidence that scrapie has an independent genome. J Gen Virol 68: 79-89.
9. Bruce ME, McConnell I, Fraser H, Dickinson AG (1991). The disease characteristics of different strains of scrapie in Sine congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. J Gen Virol 72: 595-603.
10. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ (1979). Biochemistry 18: 5294-5299.
11. Collinge J, Palmer MS, Sidle KC, Hill AF, Gowland I, Meads J, Asante E, Bradley R, et al. (1995). Unaltered susceptibility to BSE in transgenic mice expression human prion protein. Nature 378: 779-783.
12. Gajdusek DC (1977). Unconventional viruses and the origin and disappearance of kuru. Science 197: 943-960.
13. Hadlow WJ (1959). Scrapie and kuru. Lancet ii: 289-290.
14. Hope J (1995). Mice and beef and brain diseases. Nature 378: 761-762.
15. Hsiao K, Groth D, Scott M, Yang SL, Serban H, Rapp D, Foster D, Torchia M, et al. (1994). Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc Natl Acad Sci (USA) 91: 9126-9130.
16. Hubank M, Schatz DG (1994). Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res 22: 5640-5648.
17. Lisitsyn N, Lisitsyn N, Wigler M (1993). Cloning the differences between two complex genomes. Science 259: 946-951.
18. Manuelidis EE, Manuelidis L (1979). Clinical and morphological aspects of transmissible Creutzfeldt-Jakob Disease. Prog Neuropath 4: 1-26.
19. Manuelidis EE, Manuelidis L (1989). Suggested links between different types of dementias: Creutzfeldt-Jakob disease, Alzheimer Disease, and retroviral CNS infections. Alzheimer Dis Assoc Disord 3: 100-109.
20. Manuelidis L (1994). The dimensions of Creutzfeldt-Jakob Disease. Transfusion 34: 915-928.
21. Manuelidis L, Fritch W (1996). Infectivity and host responses in Creutzfeldt-Jakob Disease. Virology 215: 46-59.
22. Manuelidis L, Murdoch G, Manuelidis EE (1988). Potential involvement of retroviral elements in human dementias. Ciba Found Symp 135: 117-134.
23. Manuelidis L, Sklaviadis T, Akowitz A, Fritch W (1995). Viral particles are required for infection in neurodegenerative Creutzfeldt-Jakob disease. Proc Natl Acad Sci (USA) 92: 5124-5128.
24. Manuelidis L, Sklaviadis T, Manuelidis EE (1986). On the origin and significance of scrapie associated fibrils. In: L.A. Court et al, eds., Unconventional Virus Diseases of the Central Nervous System, Masson, Paris, 221-230.
25. Ozel M, Xi Y-G, Baldauf E, Diringer H, Pocchiari M (1994). Small virus-like structure in brains from cases of sporadic and familial Creutzfeldt-Jakob disease. Lancet 344: 923-924.
26. Prusiner SB (1991). Molecular biology of prion diseases. Science 252: 1515-1522.
27. Prusiner SB, Baldwin M, Collinge J, DeArmond SJ, Marsh R, Tateishi J, Weissmann C (1995). Prions In: Murphy, F.A. et al., eds. Virus Taxonomy, Springer Verlag, Wien, 498-503.
28. Riesner D, Kellings K, Post K, Wille H, Serban H, Groth D, Baldwin MA, Prusiner SB (1996). Disruption of prion rods generates 10-nm spherical particles having high a-helical content and lacking scrapie infectivity. J Virol 70: 1714-1722.
29. Rohwer RG (1991). The scrapie agent: 'a virus by any other name'. Cur Topics Microbiol Immunol 172: 195-232.
30. Selvaggini C, DeGioia L, Cantu L, Ghibaudi E, Diomede L, Passerini F, Forloni G, Bugiani O, et al. (1993). Molecular characteristics of a protease-resistant, amyloidogenic and. neurotoxic peptide homologous to residues 106-126 of the prion protein. Biochem Biophys Acta 194: 1380-1386.
31. Simons JN, Pilot-Matias TJ, Leary TP, Dawson GJ, Desai SM, Schlauder GG, Muerhoff AS, Erker JC, et al. (1995). Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci (USA) 92: 3401-3405.
32. Sklaviadis T, Akowitz A, Manuelidis EE, Manuelidis L (1990). Nuclease treatment results, in high specific purification of Creutzfeldt-Jakob disease infectivity with a density characteristic of nucleic acid-protein complexes. Arch Virol 112: 215-229.
33. Sklaviadis T, Akowitz A, Manuelidis EE, Manuelidis L (1993). Nucleic acid binding proteins in highly purified Creutzfeldt-Jakob disease preparations. Proc Natl Acad Sci (USA) 90: 5713-5717.
34. Sklaviadis T, Dreyer R, Manuelidis L (1992). Analysis of Creutzfeldt-Jakob disease infectious fractions by gel permeation chromatography and sedimentation field flow fractionation. Virus Res 26: 241-254.
35. Telling GC, Scott M, Mastrianni J, Gabizon R, Torchia M, Cohen FE, DeArmond SJ, Prusiner SB (1995). Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83: 79-90.